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ABSTRACT 
 
We report the establishment of a reverse-genetics system for the rescue of recombinant influenza C/JJ/50 
virus from seven plasmids. The nucleotide sequence of the whole C/JJ/50 genome was determined and full-
length cDNAs were cloned into an RNA pol I/pol II-based bidirectional vector. Transfection of Vero cells 
and subsequent amplification on MDCK cells yielded viral HA titres of 128. The utility of this bidirectional 
approach was proved by generating a reassortant virus encoding the NS segment from strain C/JHB/1/66 and 
a virus with mutations in the noncoding ends of PB1. The latter virus, which has a base-pair mutation within 
the proposed double-stranded region of the PB1 termini, exhibited impaired replication. In conclusion, our 
efficient seven-plasmid system for the rescue of recombinant influenza C virus may be used to study the 
influenza C virus life cycle in more detail and for generation of influenza C virus-based vectors. 
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INTRODUCTION 
 
Influenza C virus is a member of the Orthomyxoviridae, 
which are characterised by a segmented single-stranded 
RNA genome of negative polarity. Whereas influenza A 
and B viruses bear eight RNA segments, the genome of 
influenza C virus comprises seven RNA segments. The 
two other family members, Thogotovirus and Isavirus, 
have six and eight RNA segments, respectively. 
 
The first described reverse-genetics system for influenza A 
viruses was based on in vitro transcribed viral RNA 
(vRNAs), which were assembled with purified polymerase 
proteins (PB2, PB1, PA) and nucleoprotein (NP) to form 
ribonucleoprotein (RNP) complexes. RNPs were 
transfected into eukaryotic cells, and subsequent infection 
with a helper virus resulted in generation of recombinant 
viruses. More recently, systems for the generation of 
recombinant orthomyxoviruses entirely from cloned 
cDNAs were established for influenza A virus, influenza B 
virus, and Thogoto virus. Here, initial studies were based 
on the transfection of at least 12 plasmids: Eight plasmids 
(in case of influenza A and B viruses) harbouring the full-
length cDNAs cloned between human RNA polymerase I 
promoter and murine RNA polymerase I terminator for 
vRNA replication, as well as plasmids for protein 
expression of at least PB2, PB1, PA, and NP. 
Subsequently, bidirectional vector systems were 
established for influenza A and B viruses to restrict the 
number of plasmids to be transfected to eight: Full-length 
cDNAs were inserted between RNA polymerase I 
promoter and terminator as well as RNA polymerase II 
promoter and termination signal in opposite directions to 
yield all eight vRNAs and all viral mRNAs simultaneously 
(reviewed in: Palese and Shaw, 2007). Since then, two 
groups have developed a system for the generation of 
recombinant influenza C viruses (Crescenzo-Chaigne and 
van der Werf, 2007; Muraki et al, 2007), using seven 
plasmids for production of vRNAs plus protein expression 
plasmids. Here, we describe the first reverse-genetics 
system for influenza C virus, which is based on tranfection 
of only seven bidirectional plasmids. 240 
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Having established this efficient and easy to handle 
system, we generated a reassortant virus harbouring the six 
large segments from strain C/JJ/50 and the NS segment 
from C/JHG/66. We also applied our system to study the 
effect of mutations within the noncoding (nc) ends of one 
viral segment. 
 
The coding region of each genomic influenza virus RNA 
is flanked by nc sequences at both ends of the segment. 
Extensive studies have been carried out to elucidate the 
nature and function of the nc regions mainly of influenza 
A viruses. The ultimate nucleotides are highly conserved 
among the segments and are partially complementary, 
which allows a base-paired duplex region of four to eight 
nucleotides between the 3’end (starting from nucleotide 
10) and the 5’end (starting from nucleotide 11’ – note that 
nucleotides are counted from both ends, 5’ nucleotides are 
marked with a prime) in case of influenza A virus. This 
partially double-stranded region was first described as a 
panhandle/fork structure and was found to be required for 
vRNA and cRNA promoter activity, endonuclease activity 
of the viral polymerase complex, and mRNA 
polyadenylation (reviewed in: Palese and Shaw, 2007). 
Flick and colleagues (Flick et al, 1996; Flick and Hobom, 
1999) extended this model introducing a corkscrew 
structure, according to which the ultimate nine nucleotides 
of each end form a local secondary structure. Analysis of 
the nc ends of influenza C virus revealed that a double-
stranded region of at least five base pairs is possible 
between nucleotides 10 to 14 of the 3’end and nucleotides 
11’ to 15’ of the 5’end, consistent with the panhandle/ 
corkscrew model for influenza A virus.  
 
In the present study, we introduced a single mutation as 
well as a base-pair substitution into the nc ends of segment 
PB1. No recombinant virus could be rescued with the 
single nucleotide mutation. When the PB1 construct with 
the double mutation restoring the double-stranded region 
was employed, we succeeded in rescuing recombinant 
virus, which exhibited an impaired growth in comparison 
to wild-type virus. 
 
MATERIALS AND METHODS 
 
Cells and Viruses 
Vero and MDCK cells were maintained in Dulbecco’s 
modified Eagle’s medium and minimal essential medium, 
respectively, supplemented with 10% (v/v) fetal calf serum 
and 2 mM L-glutamine. Cells were grown at 37°C and 5% 
(v/v) CO2 prior to infection. Wild-type viruses of the strains 
C/JJ/50 and C/JHB/1/66 were grown in the amniotic cavity 
of 9-day-old embryonated chicken eggs at 33°C. 
 
Sequencing of 3’- and 5’-noncoding ends of viral RNA 
segments 
In order to determine the 3’- and 5’-nc regions of the   
influenza C/JJ/50 virus, first strand cDNA synthesis was 
performed using the SMART technology (Clontech) with 
modifications according to Matz (Matz, 2003), and nc ends 
were amplified by 3’ and 5’ RACE-PCR. First, virus was 
purified by ultracentrifugation through a 20% (w/v) sucrose 
cushion for 90min at 116,000xg and 4°C, and then treated 
with benzonase (Sigma) at room temperature for 30min to 
eliminate host cell-derived nucleic acids. Then, viral RNA 
was isolated with the QiaAmp viral RNA mini kit (Qiagen) 
largely according to the manufacturer’s instructions, except 
that no carrier-RNA was added, and vRNA was added to a 
polyadenylation reaction using the Poly(A) Tailing Kit from 
Ambion. After polyadenylation, vRNA was again purified 
with the QiaAmp viral RNA mini Kit (with the addition of 
carrier-RNA). First strand cDNA was prepared using 
RevertAidTM H Minus M-MuLV Reverse Transcriptase 
(Fermentas), using the primer TRsa, 5’CGCAGTCGG 
TACTTTTTTTTTTTTTTTTTTCA, which base-pairs with 
the oligo(A) tail of the vRNA and adds a known sequence to 
the 5’end of the cDNA, and the primer TS, 5’AAGCAGT 
GGTATCAACGCAGAGTACGCrGrGrG. The oligo(rG) 
of the latter primer can base-pair with CCC added to the 
3’end of the cDNA by M-MuLV Reverse Transcriptase, and 
the enzyme switches the templates and continues replication 
using the TS-oligo as template. The viral 5’-nc ends were 
then amplified with internal forward primers and primer TS-
PCR, 5’AAGCAGTGGTATCA ACGCAGAGT, while the 
viral 3’ends were manifolded with primer TRsa and internal 
reverse primers. Finally, PCR products were purified with 
the Wizard SV Gel and PCR Clean-Up System from 
Promega and were sequenced by Eurofins MWG Operon 
(Germany). Oligonucleotide primers were obtained from 
VBC-Biotech (Austria). Sequences of internal primers and 
PCR programmes can be provided on request. 
 
Construction of a bidirectional plasmid and insertion 
of viral segments 
In the first step to construct the bidirectional expression 
plasmid pPMV, the CMV promoter, the multiple cloning 
site and the SV40 polyadenylation signal from the pCI 
vector (Promega) were inserted into the EcoO109I and 
SapI restriction sites of pUC18. Then, 236 nucleotides of 
the human RNA polymerase I promoter, two BsmBI 
restriction sites and 33 nucleotides of the murine RNA 
polymerase I terminator sequence were inserted into the 
XbaI/XhoI window between the SV40 poly(A) signal and 
the CMV promoter (Figure 1). The sequence of vector 
pPMV is available in the GenBank Database. Viral RNA 
from egg-grown influenza C/JJ/50 virus was prepared with 
the QiaAmp viral RNA mini kit (Qiagen) according to the 
manufacturer’s instructions, vRNA was reverse-
transcribed with RevertAid
TM H Minus M-MuLV Reverse 
Transcriptase (Fermentas), and the seven full-length viral 
segments were amplified with primers complementary to 
the last twelve nucleotides using Herculase II Fusion DNA 
Polymerase (Stratagene). Four silent mutations were 
cloned into segment P3 by site-directed mutagenesis. The 
seven segments were inserted into pPMV via BsmBI 
restriction sites yielding the seven bidirectional plasmids 
pPMV-PB2, -PB1, -P3m, -HEF, -NP, -M, and -NS. To 
generate a bidirectional vector encoding the NS segment 
from strain C/JHB/1/66, vRNA from this strain was 
extracted, and the segment was amplified as described 
above. For cloning of pPMV-PB1-5’m, where the wild-
type A at position 13’ of the viral 5’-nc sequence is 
substituted by a G, cDNA was amplified with the 12-
nucleotide primer complementary to the 3’end as for wild-
type PB1 together with a 13-nucleotides long primer 
harbouring the nucleotide substitution for the 5’end. 
Plasmid pPMV-PB1-5’-3’m has the nucleotide 241 
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substitution at position 13’ of the 5’end as described above 
and an additional substitution at position 12 of the 3’end: 
The wild-type U was replaced by a C, again by site-
directed mutagenesis. At least three clones of every 
construct were sequenced. Primer sequences and PCR 
programmes are available upon request. 
 
 
 
 
Figure 1. The cloning vector pPMV allows transcription of 
inserted cDNA in both orientations by opposed promoters and 
termination signals. The seven influenza C virus cDNA segments 
were ligated into the two BsmBI restriction sites leading to 
nucleotide-exact insertion between polymerase I terminator and 
promoter for vRNA replication. mRNA is synthesised by CMV 
promoter and SV40 poly(A) signal. (In bold: BsmBI restriction 
sites. Shaded: End sequences of murine polymerase I terminator 
and human polymerase I promoter.) 
 
 
Transfection and rescue of recombinant viruses 
Ninty percent confluent Vero cells, seeded on 35mm 
plates, were transfected with 0.5µg per bidirectional 
plasmid and 10µl Lipofectamine 2000 (Invitrogen). 
Transfection was performed in Opti-MEM with Glutamax 
(Invitrogen) according to the manufacturer’s instructions. 
Six hours post transfection, cells were washed twice with 
Opti-MEM and incubated with 3ml Opti-MEM 
supplemented with Glutamax and 1µg/ml TPCK-trypsin 
(Sigma) at 33°C. TPCK-trypsin was added to the medium 
every second day. Seven days after transfection, 
supernatants were collected, and MDCK cells or fresh 
Vero cells were infected with 200µl of supernatants. Cells 
were again maintained in Opti-MEM with Glutamax and 
TPCK-trypsin. Four to eight days post infection (p.i.) – as 
soon as a cytopathic effect became visible – supernatants 
were tested for haemagglutination (HA). HA tests were 
performed as previously reported (Regl et al, 1999) with 
0.5% (v/v) of human erythrocytes obtained from the local 
blood bank. HA titres were expressed as the reciprocal of 
the highest virus dilution resulting in full agglutination of 
erythrocytes. 
vRNA isolation, RT-PCR and sequencing of 
recombinant viruses 
To confirm the rescued recombinant viruses, one-
millilitre fractions of cell-culture supernatants with HA 
titres of 64 to 128 were purified by centrifugation 
through a 20% (w/v/) sucrose cushion for 90min at 
116,000xg and 4°C. vRNA was isolated using the 
QiaAmp viral RNA mini kit (Qiagen) according to the 
manufacturer’s recommendations and subsequently 
digested with DNase I to eliminate any plasmid 
contamination. For the recombinant wild-type C/JJ/50 
virus, RT-PCR was performed with primers specific for 
segment P3 to amplify a 1287-nucleotide fragment 
containing the four silent mutations. For the recombinant 
virus with the NS segment from C/JHB/1/66, the first 
560 nucleotides of NS were amplified. Finally, for virus 
r-C/JJ/50-PB1-5’-3-m, the 5’- and 3’-nc regions were 
amplified with primers complementary to the last 12 and 
11 nucleotides, respectively, together with internal 
primers. The purified PCR products were sequenced by 
Eurofins MWG Operon (Germany). Primer sequences 
can be provided on request. 
 
Nucleotide sequence accession numbers 
The GenBank/EMBL/DDJ accession numbers for PB2, 
PB1, HEF, NP, M, NS, and vector pPMV are FR671420, 
FR671421, FR671422, FR671423, FR671424, FR671425, 
and FR669675, respectively. 
 
RESULTS 
 
Complete sequences of the 3’ and 5’ends of all seven 
segments from influenza C/JJ/50 virus 
First, we determined the 3’ and 5’ends of the seven viral 
segments from strain C/JJ/50. In the 1980s, the complete 
cDNA sequences including the nc regions of segments PB2, 
PB1, P3, and M from influenza C/JJ/50 virus were 
published (Yamashita et al, 1988; 1989). Our analyses 
revealed some differences in comparison with these 
sequences. For the 3’-nc ends (see Table 1) we observed 
that the first eleven nucleotides and nucleotide 14 are 
identical in all seven segments, whereas nucleotides 12 and 
13 show a slight variability: The two largest segments PB2 
and PB1 have a U at position 12, while all other segments 
have a C at this position. Nucleotide 13 is a C in all 
segments except for NP, which has a U at this position. 
Regarding the viral 5’ends, the first twelve nucleotides as 
well as nucleotide 15’ are conserved among the segments, 
with exception of the NS segment, where nucleotide 6’ 
differs from the others (see Table 1). Concerning the two 
variable positions 13’ and 14’, PB2 and PB1 harbour an A 
at position 13’, while the other segments have a G, and NP 
has an A at position 14’, where all other segments have a G. 
Our results coincide with recent sequence analyses from 
strain C/JHB/1/66 (Crescenzo-Chaigne and van der Werf, 
2007) and strain C/AnnArbor/1/50 (Muraki et al, 2007). In 
all segments, nucleotides 10-14 are complementary to 
nucleotides 11’-15’, which supports the idea that influenza 
C virus RNAs form a double-stranded structure of five base 
pairs at this region (Crescenzo-Chaigne and van der Werf, 
2001). Actually, segments PB2, PB1, P3, NP, and M of 
C/JJ/50 are even capable of forming six base pairs. If the 
poly(U) stretch was included, double-stranded regions242 
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Table 1. Comparison of the conserved 3’- and 5’-noncoding ends of the vRNA segments from influenza C/JJ/50 virus. 
Segment  3’ nc end (ultimate 20 nucleotides)
a  5’ nc end (first 20 nucleotides)
a 
PB2
b UCCAAUCCUCUGCUUCUGCU AGCAGUAGCAAGAGGAUUUU 
PB1
b CAUAAUCCUCUGCUUCUGCU AGCAGUAGCAAGAGGAUUUU 
P3 UCGGAUCCCCUGCUUCUGCU AGCAGUAGCAAGGGGAUUUU 
HEF AUUAAACCCCUGCUUCUGCU AGCAGUAGCAAGGGGAUUUU 
NP
b CAAAAUCUCCUGCUUCUGCU AGCAGUAGCAAGGAGAUUUU 
M AGAAAUCCCCUGCUUCUGCU AGCAGUAGCAAGGGGAUUUU 
NS
b AAAGUACCCCUGCUUCUGCU AGCAGGAGCAAGGGGUUUUU 
aUnderlined: Conserved sequences. 
bIn bold: Variations at positions 12, 13, 6’, 13’ and 14’. 
Note that sequences are shown in 5’-3’ orientation and numbering of nucleotides starts from both ends. 
 
 
of between five to ten base pairs would be possible. 
Additionally, in accordance with the corkscrew model 
(Flick et al, 1996) for influenza A virus RNAs, our results 
show that base pairing may occur between nucleotides 2 
and 9, 3 and 8 as well as 2’ and 9’ and 3’ and 8’. 
 
Cloning of the seven C/JJ/50 segments and the NS 
segment from C/JHB/1/66 into vector pPMV and 
sequencing of the whole C/JJ/50 genome 
We constructed the bidirectional vector pPMV, which 
allows transcription of viral genomic RNA and mRNA from 
one template. The human RNA polymerase I promoter and 
the murine RNA polymerase I terminator ensure exact 
synthesis of viral RNA, while CMV promoter and SV40 
poly(A) signal direct mRNA transcription. We amplified the 
seven full-length viral segments using primers 
complementary to the ultimate 12 nucleotides and cloned 
them into the two BsmBI restriction sites of pPMV (see 
Figure 1). To assure that rescued virus is recombinant and 
not the result of a contamination with wild-type virus, four 
silent mutations were introduced into the coding sequence 
of segment P3, the resulting plasmid was termed pPMV-
P3m. At least three clones of every segment were 
sequenced, and the consensus sequence of the whole 
influenza C/JJ/50 virus genome was determined. The 
sequences of PB2, PB1, P3, and M were compared to the 
available sequences in the GenBank database. Our PB2 
sequence differs from the published sequence M28061 by 
one nucleotide in the 3’-nc end. PB1 has one different 
nucleotide resulting in a silent mutation as well as one 
different nucleotide in each nc end compared to M28060. 
No difference was found for P3 in comparison with 
M28062. Segment M has one nucleotide difference leading 
to a different amino acid in the ORF of CM2 compared to 
the published sequence M22038. Not only sequencing of 
three different M clones but also direct cDNA end 
sequencing confirmed the nucleotide difference. Segments 
HEF, NP, and NS from C/JJ/50 had not been published 
before. The NP segment is known to be of variable length 
among different strains. We have determined that NP from 
strain C/JJ/50 is 1802 nucleotides long as NP from 
C/JHB/1/66 (AF170573). Compared to strains C/Cal/78 
(M17700) and C/AnnArbor/1/50 (AB126195), it has a 
deletion of five nucleotides in the ORF near the 3’end 
(regarding positive-sense polarity) leading to an earlier stop 
codon, and is consequently nine amino acids shorter. NP 
from C/JJ/50 has another deletion of two nucleotides in the 
5’-nc end (vRNA polarity) in comparison with NP from 
C/Cal/78. Most interestingly, the NS segment from strain 
C/JJ/50 is 21 nucleotides shorter than any to our knowledge 
published NS sequence. Sequence comparison revealed that 
nucleotides 239-259 (in cDNA polarity) are missing in 
C/JJ/50, leading to a deletion of amino acids 72-78 in the 
ORF of NS1. The NS segment from strain C/JJ/50 therefore 
encodes a 239-amino acid NS1 protein, in contrast to the 
246-amino acid NS1 proteins from other influenza C virus 
strains (Alamgir et al, 2000). As this nucleotide deletion is 
within the region spliced from NEP/NS2 mRNA, the 
NEP/NS2 ORF from C/JJ/50 is not affected and codes for a 
182-amino acid protein – as reported for other strains 
(Alamgir et al, 2000). We consequently decided to 
additionally clone the NS segment from strain C/JHB/1/66 
(pPMV-NS-C/JHB/1/66). The sequences of the influenza 
C/JJ/50 virus genome with exception of P3 were deposited 
at the GenBank Database. 
 
Rescue of infectious influenza C/JJ/50 virus 
To rescue recombinant wild-type C/JJ/50 virus entirely 
from cloned cDNA, we transfected the seven bidirectional 
vectors encoding the seven segments (pPMV-PB2, -PB1, -
P3m, -HEF, -NP, -M, and -NS) into Vero cells. Cells had 
to be 90% confluent to survive transfection and the 
following incubation in serum-free medium with trypsin 
added. Seven days after transfection, supernatants were 
collected but HA titration was not sensitive enough to 
determine virus yield. We therefore passed the 
supernatants to fresh Vero cells or MDCK cells, the latter 
of which highly promote growth of influenza C virus. Four 
to six days p.i. of MDCK cells with transfection 
supernatants, cells became cytopathic and supernatants 
were harvested. HA titres of 128 could be determined in 
five independent experiments (see Table 2). Passing the 
transfection supernatants to fresh Vero cells led seven to 
eight days p.i. to HA titres of 64. RNA of infectious 
supernatants was prepared, and a fragment of P3 covering 
the introduced silent mutations was reverse-transcribed 
and PCR-amplified. Sequence analysis verified the four 
silent mutations, confirming that the recovered virus was 
derived from plasmids. 
 
Replication of recombinant and wild-type viruses 
C/JJ/50 and C/JHB/1/66 
As mentioned before, the NS segment of strain C/JJ/50 has 
a deletion of 21 nucleotides in comparison with other243 
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Table 2. Rescue of recombinant influenza C viruses by plasmid transfection of Vero cells and subsequent amplification on MDCK cells. 
 
Virus
a  Expt 1  Expt 2  Expt 3  Expt 4  Expt 5 
rwt-C/JJ/50  HA = 128  HA = 128  HA = 128  HA = 128  HA = 128 
r-C/JJ/50:NS-JHB  HA = 128  HA = 64  HA = 256     
r-C/JJ/50:PB1-5’-3’m        HA = 64  HA = 16 
aRescued viruses: rwt-C/JJ/50: recombinant wild-type C/JJ/50, r-C/JJ/50:NS-JHB: recombinant reassortant virus with the six large 
segments from C/JJ/50 and NS from C/JHB/1/66, r-C/JJ/50:PB1-5’-3’m: recombinant virus C/JJ/50 with one mutation in each nc region of 
PB1. HA titres are expressed as reciprocal of the highest virus dilution resulting in agglutination of red blood cells. 
 
 
strains, which results in a deletion of seven amino acid 
residues at positions 72–78 in the NS1 coding sequence. 
We therefore decided to generate an influenza C virus 
harbouring the six large segments (PB2, PB1, P3, HEF, 
NP, and M) from C/JJ/50 and the NS segment from strain 
C/JHB/1/66. HA titres of 128, 64 and 256 were measured 
in three independent experiments (see Table 2). The NS 
segment was sequenced to confirm the reassortant virus. In 
order to find out, whether there is any difference in 
replication of recombinant wild-type C/JJ/50 virus, wild-
type C/JJ/50 virus and recombinant reassortant virus (NS: 
C/JHB/1/66), we determined the growth kinetics of these 
three viruses as well as of wild-type C/JHB/1/66 virus on 
MDCK and Vero cells. Both cell lines were infected with 
viruses of HA titres 128, which were diluted 1:10,000, and 
the amount of virus released to the medium was tested 
daily. Two days p.i. of MDCK cells, wild-type and 
recombinant wild-type C/JJ/50 viruses were measurable 
(HA titres of 4 and 8, respectively, see Fig. 2A). Virus 
yield doubled approximately each day, reaching an HA 
titre of 256 six to seven days p.i. No higher titres could be 
gained, as cells were already cytopathic. Wild-type 
C/JHB/1/66 and recombinant reassortant virus with the NS 
segment from C/JHB/1/66 exhibited a slightly delayed 
growth (Figure 2A). Three days p.i., titres of 2 were 
determined. Seven days p.i., when cells were cytopathic, 
titres of 128 were measured. 
 
In Vero cells, the four strains replicated identically fast 
(see Figure 2B). An HA titre of 4 was measured four days 
p.i. Seven to eight days p.i., virus titres of 64 were 
reached. At that time, Vero cells exhibited a cytopathic 
effect. 
 
Generation of recombinant virus with mutations in the 
3’ and 5’ nc ends of PB1 and growth kinetics 
We exploited our established reverse-genetics system to 
study the effect of mutations in the double-stranded region 
of the proposed panhandle/corkscrew-structured vRNA 
ends (see Figure 3A). To this end we constructed two 
bidirectional plasmid vectors for PB1. Vector pPMV-PB1-
5’m has a single mutation at position 13’ of the viral 5’-nc 
region: The wild-type A was replaced by a G (A→G[13’]), 
which is noticeably the wild-type nucleotide 13’ of 
segments P3, HEF, NP, M and NS. But this single 
nucleotide exchange disrupts the base-paired duplex 
region. Vector pPMV-PB1-5’-3’m has a base-pair 
mutation: It harbours the above described nucleotide 
exchange at the 5’end as well as a nucleotide exchange at 
position 12 of the 3’end. Here, the wild-type U was replaced 
by a C (A–U→G–C[13’–12]),  which  again  represents  the 
 
 
Figure 2. Comparison of the growth behaviour of wild-type 
C/JJ/50 and C/JHB/1/66 viruses with recombinant wild-type 
virus and recombinant reassortant virus on (A) MDCK cells and 
(B) Vero cells. Confluent cells were infected with the respective 
virus (amplified on MDCK cells to HA titres of 128, diluted 
1:10,000) in the presence of 1 µg/ml TPCK-trypsin. Samples of 
supernatants were collected every day and virus titres were 
determined by HA test. Viruses: wild-type C/JJ/50, recombinant 
wild-type C/JJ/50, wild-type C/JHB/1/66, r-C/JJ/50:NS-JHB: 
recombinant reassortant virus with the six large segments from 
C/JJ/50 and NS from C/JHB/1/66. 
 
 
wild-type nucleotide 12 of segments P3, HEF, NP, M, and 
NS. (Figure 3B). Transfection of Vero replaced cells with 
the wild-type vectors for PB2, P3, HEF, NP, M, and NS 
along with pPMV-PB1-5’m and passage of the supernatant 
to MDCK cells for further viral growth did not result in the 
generation of a recombinant virus in two independent 
experiments. On the other hand, when transfecting the six 
wild-type segments along with pPMV-PB1-5’-3’m, which 
has one nucleotide exchange in each nc end restoring 
complementarity (Figure 3), recombinant viruses with HA 
titres of 64 and 16 were gained after six days of growth on 
MDCK cells (see Table 2, this virus was named r-
C/JJ/50:PB1-5’-3’m). The presence of the two mutations 244 
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was confirmed by sequencing the viral ends. As the yield 
was lower than that of recombinant wild-type virus, we 
compared the growth kinetics of recombinant wild-type 
C/JJ/50 virus and virus r-C/JJ/50-PB1-5’-3’m. We infected 
MDCK cells with viruses of HA titres 64, diluted 1:5,000, 
and tested the HA titres daily. Recombinant wild-type virus 
again reached an HA titre of 256 six days p.i. (Figure 4), 
while virus r-C/JJ/50-PB1-5’-3’m showed a delayed 
growth kinetic reaching a maximum HA titre of 64 five 
days p.i. In conclusion, the base pair-mutated virus 
exhibited a 4-fold reduction in growth. 
 
 
 
Figure 3. Representation of the nc terminal sequences of PB1 
vRNA from influenza C virus in the corkscrew model in A ( 
Flick et al, 1996; Crescenzo-Chaigne and van der Werf, 2001), 
and single/base-pair mutations at positions 13’ and 12 within the 
proposed six base pairs long double-stranded region in B. 
Numbering of residues starts from the 3’end and the 5’ end; 5’ 
residues are marked with a prime, and base pairs are joined by 
lines in (A). 
 
 
 
 
Figure 4. Growth kinetics of recombinant virus with base-pair 
mutation in the noncoding ends of PB1. Confluent monolayers of 
MDCK cells were infected with recombinant wild-type C/JJ/50 
virus (rwt-C/JJ/50) and with recombinant virus harbouring the 
base-pair mutation A–U→G–C(13’–12) in the nc terminal 
sequences of PB1 (r-C/JJ/50:PB1-5’-3’m). Both viruses were 
grown on MDCK cells to an HA titre of 64 and were diluted 
1:5,000 prior to infection. Samples of the supernatants were 
tested for haemagglutination daily. 
DISCUSSION 
 
In the present study, we report the successful generation of 
recombinant influenza C virus entirely from seven 
bidirectional plasmids. While the employment of 
bidirectional vectors has already been described for 
influenza A and B viruses (Dauber et al, 2004; de Wit et 
al, 2004; Hoffmann et al, 2000; 2002), this is the first 
report for influenza C viruses. 
 
As a prerequisite to produce recombinant influenza C 
viruses, we determined the consensus sequence of the 
C/JJ/50 genome. Surprisingly, we found that the NS 
segment from C/JJ/50 is 21 nucleotides shorter than the 
respective of other strains. This deletion results in an NS1 
protein missing amino acids 72–78 in comparison with 
other strains. As a consequence, we included the NS 
segment from strain C/JHB/1/66 in our experimental 
system. 
 
We designed a bidirectional vector for vRNA replication 
and mRNA transcription from one template (see Fig. 1), as 
initially established by Hoffmann et al (2000). We decided 
to transfect our plasmids into Vero cells instead of 293T 
cells, which were used to produce recombinant influenza 
C viruses by two other groups (Crescenzo-Chaigne and 
van der Werf, 2007; Muraki et al, 2007), as we observed 
that Vero cells promote growth of influenza C viruses and 
are well transfectable. Although they cannot compete with 
293T cells in transfection efficiency, 293T cells on the 
other hand are very sensitive to trypsin and therefore hard 
to handle. We transferred the Vero cell-supernatants seven 
days post transfection to MDCK cells, which highly 
support influenza C virus replication, and could 
consequently abstain from using embryonated chicken 
eggs for further growth. It should be mentioned that Vero 
as well as MDCK cells are permitted for vaccine 
production. Infection of MDCK cells resulted in average 
HA titres of 128 five days p.i. for recombinant wild-type 
viruses (see Table 2). Plaque assays previously performed 
in our lab with wild-type C/JJ/50 virus let us conclude that 
an HA titre of 128 approximately equals 10
9 plaque 
forming units (p.f.u.)/ml. In comparison, Muraki et al 
(2007) recovered recombinant influenza C viruses with 
maximum titres of 2,5 X 10
3 EID50/ml by transfection of 
11 to 16 plasmids into 293T cells and inoculation of 
transfection supernatants after 48 to 60 hours in chicken 
eggs. Crescenzo-Chaigne and van der Werf (2007) 
transfected 11 plasmids into 293T cells and measured 10
3 
to 10
4 p.f.u./ml eight to ten days post transfection. 
Transferring the supernatants into chicken eggs led to 
titres of 10
9 p.f.u./ml, whereas further growth on SK 93/2 
cells yielded 10
5 to 10
6 p.f.u./ml. We conclude that our 
system is competitive in comparison with the above 
described ones regarding virus yield referred to time 
expended. Moreover, our seven-plasmid system is less 
time-consuming. Seven plasmids are faster constructed, 
and transfection experiments are easier to handle. Using 
this system, mutations can be easily introduced into the 
viral genome.  
 
After having established this system, we created a 
reassortant virus bearing the NS segment of strain 245 
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C/JHB/1/66 to assess whether the seven amino acids 
smaller NS1 from C/JJ/50 has any effect on growth 
behaviour. Viral titres comparable to those gained from 
transfection of all seven C/JJ/50 segments were measured. 
Growth curves indicated that wild-type C/JHB/1/66 virus 
and reassortant virus replicated more slowly than wild-
type and recombinant wild-type C/JJ/50 viruses on MDCK 
cells, while growth on Vero cells was equal (Figure 2, A 
and B). In summary, the recombinant wild-type C/JJ/50 
virus replicated as fast as the mother strain on MDCK and 
Vero cells. There was no remarkable difference in virus 
titres between wild-type C/JJ/50 and C/JHB/1/66 viruses 
and the two recombinant strains. The missing seven amino 
acids of NS1-C/JJ/50 do not appear to play an important 
role for growth on MDCK and Vero cells. 
 
We next tried to recover recombinant viruses with 
mutations in the nc ends of PB1. The nc ultimate 
nucleotides of the viral segments are described as partially 
double-stranded panhandle/RNA fork/corkscrew structures 
for influenza A viruses (Flick et al, 1996; Fodor et al, 1994; 
Hsu et al, 1987). We introduced a single mutation at 
position 13’ of the 5’ nc end of segment PB1 (A→G[13’]), 
which abolishes the postulated base pairing between 
nucleotides 10 to 15 of the 3’ end and 11’ to 16’ of the 5’ 
end. Indeed, this mismatch prevented the rescue of a 
recombinant virus. When this single mutation at the 5’ end 
was supplemented by a second mutation at the putative 
base-pairing partner at the 3’ end (A–U→G–C[13’–12]), a 
recombinant virus was gained (see Fig. 3), but growth 
kinetics were slower in this strain (see Fig. 4). While the 
wild-type recombinant virus grew to an HA titre of 256, the 
recombinant mutant virus replicated to an HA titre of 64. 
According to previously performed plaque assays with wild-
type virus, an HA titre of 256 corresponds to 2.5 X 10
9 
p.f.u./ml, and an HA titre of 64 to 4 X 10
8 p.f.u./ml. 
Importantly, only segments PB2 and PB1 have A and U at 
positions 13’ and 12, respectively. All other segments have 
the G–C base pair. Fodor et al  (1998) suggested that 
impaired growth of such base-pair mutants in influenza A 
viruses is due to impaired polyadenylation properties. They 
observed that neither vRNA nor cRNA levels were declined 
but mRNA and protein levels. Initiation and elongation of 
transcription equalled wild type, but the mutations interfered 
with polyadenylation of the mRNA transcripts. We have not 
determined the exact reason for the lower viral titres of our 
base-pair mutant, but find that not only the base-pairing 
ability, but also a particular nucleotide sequence at the 
panhandle/corkscrew region is important. 
 
In the future, our seven plasmid-based system may be 
useful to study transcription, replication and packaging 
events and to elucidate the function of proteins from 
influenza C virus. The influenza C virus NS1 protein for 
example would be a candidate antagonist of the cellular 
interferon system, which could be assessed by generating 
NS1-deficient influenza C viruses. Several melanoma cell 
lines have a defective interferon signalling and express the 
cellular receptor for influenza C viruses, which is 9-O-
acetyl sialic acid (reviewed in: Kohla et al, 2002; Varki 
and Varki, 2007). Thus an attenuated recombinant 
influenza C virus could be employed as gene delivery 
vector and/or tumour-specific oncolytic virus. 
CONCLUSIONS 
 
The generation of recombinant influenza C viruses from 
seven bidirectional plasmids is an efficient system with 
regards to virus yield and time spent. Employing certified 
Vero and MDCK cells, this system is independent of the 
use of embryonated chicken eggs for virus amplification. 
Studies on the generation of influenza C viruses with 
mutations in the nc ends of PB1 indicate that base pairing 
between the viral ends is indispensable for virus rescue, 
and the exact nature of each nucleotide in the nc regions 
strongly influences viral titres. 
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d.p.i.: days post infection 
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nc: noncoding 
NP: nucleoprotein 
p.f.u.: plaque forming units 
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